1 Min Read
Oct 16 (Reuters) - PROBIODRUG AG:
* PROBIODRUG INITIATES PHASE 2B CORE PROGRAM OF PQ912 AND DETAILS FURTHER STRATEGY Source text for Eikon: Further company coverage: (Gdynia Newsroom)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.